HedgePath Pharmaceuticals (HPPI) Stock Chart & Stock Price History $0.04 -0.01 (-12.77%) As of 08/8/2025 Add Compare Share Share Chart Stock AnalysisChartSEC FilingsBuy This Stock HedgePath Pharmaceuticals Stock Price Performance The HedgePath Pharmaceuticals (HPPI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 40.79%, with a year-to-date return of -38.32%. In the past month, the stock has decreased 16.33%, reflecting recent market activity. As of the latest close, HedgePath Pharmaceuticals traded at $0.04 with a market cap of $15.19 million and volume of 28,650 shares. Five years ago, the stock traded at $0.06, representing a 31.67% decrease over that period. At the time, it had a market cap of $22.23 million and a volume of 0 shares. Receive HPPI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for HedgePath Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month PerformanceN/A3 Month Performance-31.61%Year-To-Date Performance-38.32%1 Year PerformanceN/A5 Year PerformanceN/A HPPI Stock Chart for Saturday, August, 16, 2025 HPPI Chart by TradingView HedgePath Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/15/2025$0.04$0.04$0.05$0.0428,650 shs$15.19 million08/14/2025$0.04$0.04$0.05$0.0428,650 shs$15.19 million08/13/2025$0.04$0.04$0.05$0.0428,650 shs$15.19 million08/12/2025$0.04$0.04$0.05$0.0428,650 shs$15.19 million08/11/2025$0.04$0.04$0.05$0.0428,650 shs$15.19 million08/08/2025$0.05$0.05$0.05$0.051,138 shs$19.26 million08/07/2025$0.05$0.05$0.05$0.051,138 shs$19.26 million08/06/2025$0.05$0.05$0.05$0.051,138 shs$19.26 million08/05/2025$0.05$0.05$0.05$0.051,138 shs$19.26 million08/04/2025$0.05$0.05$0.05$0.051,138 shs$19.26 million07/25/2025$0.05$0.05$0.05$0.057,000 shs$20.26 million07/24/2025$0.05$0.05$0.05$0.057,000 shs$20.26 million07/23/2025$0.05$0.05+13.96%$0.05$0.057,000 shs$20.26 million07/15/2025$0.05$0.05-2.00%$0.05$0.05500 shs$18.15 million Related Companies Werewolf Therapeutics Stock Chart OS Therapies Stock Chart Earth Science Tech Stock Chart Adlai Nortye Stock Chart ImmuCell Stock Chart DURECT Stock Chart Genenta Science Stock Chart SSGI Stock Chart ImageneBio Stock Chart CEL-SCI Stock Chart Receive HPPI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for HedgePath Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:HPPI) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HedgePath Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share HedgePath Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access